MARKER THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
MARKER THERAPEUTICS, INC. (MRKR) reported Earnings Per Share, Basic and Diluted of -$0.15 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-10
- MARKER THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.15.
- MARKER THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.13.
- MARKER THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.16.
- MARKER THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.17.
- MARKER THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.61.
- MARKER THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.47.
- MARKER THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$7.75.
- MARKER THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.16.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | -$0.15 10-Q · filed 2021-11-10 | -$0.43 10-Q · filed 2021-11-10 | |||||
| 2021-06-30 | -$0.13 10-Q · filed 2021-08-10 | -$0.28 10-Q · filed 2021-08-10 | -$0.45 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$0.61 derived: net income ÷ weighted average shares · filed 2022-08-11 | |||
| 2021-03-31 | -$0.16 10-Q · filed 2021-05-12 | -$0.33 derived: net income ÷ weighted average shares · filed 2022-05-13 | -$0.49 derived: net income ÷ weighted average shares · filed 2022-05-13 | -$0.62 derived: net income ÷ weighted average shares · filed 2022-05-13 | |||
| 2020-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$0.33 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$0.47 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$0.61 10-K · filed 2021-03-09 | |||
| 2020-09-30 | -$0.16 10-Q · filed 2021-11-10 | -$0.29 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$0.43 10-Q · filed 2021-11-10 | -$0.55 derived: net income ÷ weighted average shares · filed 2021-11-10 | |||
| 2020-06-30 | -$0.14 10-Q · filed 2021-08-10 | -$0.28 10-Q · filed 2021-08-10 | -$0.39 derived: net income ÷ weighted average shares · filed 2021-08-10 | -$0.51 derived: net income ÷ weighted average shares · filed 2021-08-10 | |||
| 2020-03-31 | -$0.14 10-Q · filed 2021-05-12 | -$0.25 derived: net income ÷ weighted average shares · filed 2021-05-12 | -$0.37 derived: net income ÷ weighted average shares · filed 2021-05-12 | -$0.49 derived: net income ÷ weighted average shares · filed 2021-05-12 | |||
| 2019-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2021-03-09 | -$0.23 derived: net income ÷ weighted average shares · filed 2021-03-09 | -$0.35 derived: net income ÷ weighted average shares · filed 2021-03-09 | -$0.47 10-K · filed 2021-03-09 | |||
| 2019-09-30 | -$0.12 10-Q · filed 2020-11-09 | -$0.24 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$0.36 10-Q · filed 2020-11-09 | -$3.44 derived: net income ÷ weighted average shares · filed 2020-11-09 | |||
| 2019-06-30 | -$0.12 10-Q · filed 2020-08-10 | -$0.24 10-Q · filed 2020-08-10 | -$3.35 derived: net income ÷ weighted average shares · filed 2020-08-10 | -$4.17 derived: net income ÷ weighted average shares · filed 2020-08-10 | |||
| 2019-03-31 | -$0.12 10-Q · filed 2020-05-11 | -$3.29 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$4.39 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$5.40 derived: net income ÷ weighted average shares · filed 2020-05-11 | |||
| 2018-12-31 | -$3.38 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$5.20 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$6.61 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$7.75 10-K · filed 2020-03-12 | |||
| 2018-09-30 | -$0.32 10-Q · filed 2019-11-12 | -$0.72 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$1.03 10-Q · filed 2019-11-12 | -$1.29 derived: net income ÷ weighted average shares · filed 2019-11-12 | |||
| 2018-06-30 | -$0.41 10-Q · filed 2019-08-09 | -$0.71 10-Q · filed 2019-08-09 | -$0.97 derived: net income ÷ weighted average shares · filed 2019-08-09 | -$1.36 derived: net income ÷ weighted average shares · filed 2019-08-09 | |||
| 2018-03-31 | -$0.30 10-Q · filed 2019-05-10 | -$0.55 derived: net income ÷ weighted average shares · filed 2019-05-10 | -$0.94 derived: net income ÷ weighted average shares · filed 2019-05-10 | -$1.18 derived: net income ÷ weighted average shares · filed 2019-05-10 | |||
| 2017-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$0.64 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$0.87 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.16 10-K · filed 2019-03-15 | |||
| 2017-09-30 | -$0.39 10-Q · filed 2018-11-13 | -$0.63 derived: net income ÷ weighted average shares · filed 2018-11-13 | -$0.91 10-Q · filed 2018-11-13 | ||||
| 2017-06-30 | -$0.22 10-Q · filed 2018-08-09 | -$0.51 10-Q · filed 2018-08-09 | |||||
| 2017-03-31 | -$0.29 10-Q · filed 2018-05-15 | ||||||
| 2016-03-31 | -$0.81 10-Q · filed 2017-05-05 | -$0.07 10-Q · filed 2016-05-16 | |||||
| 2015-12-31 | -$0.78 10-K · filed 2016-04-14 | ||||||
| 2015-06-30 | -$1.80 10-Q/A · filed 2016-04-14 | -$0.55 10-Q · filed 2015-08-14 | -$1.99 10-Q/A · filed 2016-04-14 | -$0.64 10-Q · filed 2015-08-14 | -$2.23 derived: net income ÷ weighted average shares · filed 2016-08-15 | -$2.52 derived: net income ÷ weighted average shares · filed 2016-08-15 | |
| 2015-03-31 | -$0.03 10-Q · filed 2016-05-16 | -$0.04 10-Q · filed 2015-05-15 | -$0.06 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$0.13 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$0.11 derived: net income ÷ weighted average shares · filed 2016-05-16 | ||
| 2014-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2016-04-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2016-04-14 | -$0.08 derived: net income ÷ weighted average shares · filed 2016-04-14 | -$2.00 10-K · filed 2016-04-14 | |||
| 2014-09-30 | -$0.09 10-Q · filed 2014-11-19 | -$0.05 derived: net income ÷ weighted average shares · filed 2016-04-14 | -$2.27 10-Q · filed 2014-11-19 | -$3.24 derived: net income ÷ weighted average shares · filed 2016-04-14 | |||
| 2014-06-30 | $0.05 10-Q/A · filed 2016-04-14 | -$2.57 10-Q/A · filed 2016-04-14 | -$3.95 derived: net income ÷ weighted average shares · filed 2016-04-14 | -$5.13 derived: net income ÷ weighted average shares · filed 2016-04-14 | |||
| 2014-03-31 | -$3.89 10-Q/A · filed 2016-04-14 | -$4.29 10-Q/A · filed 2014-05-21 | -$7.30 derived: net income ÷ weighted average shares · filed 2016-04-14 | -$9.82 derived: net income ÷ weighted average shares · filed 2016-04-14 | -$12.25 derived: net income ÷ weighted average shares · filed 2016-04-14 | ||
| 2013-12-31 | -$2.37 derived: net income ÷ weighted average shares · filed 2015-04-15 | -$3.09 derived: net income ÷ weighted average shares · filed 2015-04-15 | -$4.09 derived: net income ÷ weighted average shares · filed 2015-04-15 | -$4.87 10-K/A · filed 2014-04-17 | |||
| 2013-09-30 | -$0.76 10-Q · filed 2014-11-19 | -$0.01 10-Q · filed 2013-11-19 | -$1.43 derived: net income ÷ weighted average shares · filed 2014-11-19 | -$2.00 10-Q · filed 2014-11-19 | -$0.02 10-Q · filed 2013-11-19 | ||
| 2013-06-30 | -$0.87 10-Q · filed 2014-08-18 | -$0.01 10-Q · filed 2013-08-19 | -$1.45 10-Q · filed 2014-08-18 | -$0.01 10-Q · filed 2013-08-19 | |||
| 2013-03-31 | -$0.55 10-Q/A · filed 2014-05-21 | -$0.01 10-Q/A · filed 2013-08-19 | |||||
| 2012-12-31 | -$9.42 10-K/A · filed 2014-04-17 | ||||||
| 2012-09-30 | -$0.01 10-Q · filed 2013-11-19 | -$0.07 10-Q · filed 2013-11-19 | |||||
| 2012-06-30 | -$0.04 10-Q · filed 2013-08-19 | -$0.06 10-Q · filed 2013-08-19 | -$0.05 10-Q/A · filed 2012-09-12 | ||||
| 2012-03-31 | -$0.01 10-Q/A · filed 2013-08-19 | ||||||
| 2011-12-31 | -$0.04 10-K · filed 2013-05-15 | ||||||
| 2011-09-30 | -$0.02 10-Q · filed 2011-11-21 | -$0.05 10-Q · filed 2011-11-21 | |||||
| 2011-06-30 | -$0.01 10-Q/A · filed 2012-09-12 | -$0.04 10-Q/A · filed 2012-09-12 | |||||
| 2011-03-31 | -$0.03 10-Q · filed 2012-05-21 | ||||||
| 2010-12-31 | -$0.09 10-K · filed 2012-04-16 | ||||||
| 2010-09-30 | -$0.03 10-Q · filed 2011-11-21 | -$0.10 10-Q · filed 2011-11-21 | |||||
| 2010-06-30 | -$0.03 10-Q · filed 2011-08-22 | -$0.08 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |